Data as of Jul 25
| -0.26 / -2.38%|
The 5 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 16.00, with a high estimate of 17.00 and a low estimate of 11.00. The median estimate represents a +49.95% increase from the last price of 10.67.
The current consensus among 6 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.